Show simple item record

dc.contributor.authorSmolnikov, S.
dc.contributor.authorGorgopina, E.
dc.contributor.authorLezhnyova, V.
dc.contributor.authorOng, G.
dc.contributor.authorChui, W.
dc.contributor.authorDolzhenko, Anton
dc.date.accessioned2018-02-19T07:59:40Z
dc.date.available2018-02-19T07:59:40Z
dc.date.created2018-02-19T07:13:30Z
dc.date.issued2017
dc.identifier.citationSmolnikov, S. and Gorgopina, E. and Lezhnyova, V. and Ong, G. and Chui, W. and Dolzhenko, A. 2017. 4-Phenethylthio-2-phenylpyrazolo[1,5-a][1,3,5]triazin-7(6H)-one. MolBank. 2017 (4): M970.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/65783
dc.identifier.doi10.3390/M970
dc.description.abstract

© 2017 by the authors. Licensee MDPI, Basel, Switzerland. Exploring the pharmacologically important pyrazolo[1,5-a][1,3,5] triazin-7(6H)-one scaffold for the construction of new bioactive compounds, we developed a synthesis of 4-phenethylthio-2- phenylpyrazolo[1,5-a][1,3,5] triazin-7(6H)-one (4) via S-alkylation of 2-phenyl-4-thioxopyrazolo [1,5-a][1,3,5] triazine-7(6H)-one (3), prepared by the double ring closure of pyrazole and triazine rings upon the treatment of 1-cyanoacetyl-4-benzoylthiosemicarbazide (2) with alkali. The antiproliferative activity of 4 against human lung cancer (A549) and human breast cancer (MDA-MB231) cell lines was investigated. Compound 4 was found to be more active against lung cancer cells t han breast cancer cells.

dc.title4-Phenethylthio-2-phenylpyrazolo[1,5-a][1,3,5]triazin-7(6H)-one
dc.typeJournal Article
dcterms.source.volume2017
dcterms.source.number4
dcterms.source.issn1422-8599
dcterms.source.titleMolBank
curtin.departmentSchool of Pharmacy and Biomedical Sciences
curtin.accessStatusOpen access via publisher


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record